Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...

Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...

MSD’s Keytruda is being studied in more than 1,600 trials across various cancers and treatment settings. Credit: Katherine Welles/Shutterstock. MSD has received US Food and Drug Administration (FDA) ...